Here are four things to know:
• Argus currently has a “buy” rating on the stock.
• The company has a one-year low of $42.50 and a one-year high of $58.25.
• The stock’s 50-day moving average is $55.6 and its 200-day moving average is $50.80.
• The company has a market cap of $1.849 billion.
Separately, Zacks analysts reiterated a neutral rating and set a $54 price target on Integra shares in a research note on Dec. 18, according to the report.
More articles on devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center — 6 things to know
Revenue up, $147k net loss — 10 key points on RTI Surgical’s 2014 financial report
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
